Orano USA

Headquartered in Bethesda, Maryland, near the nation's capital, Orano USA is a leading technology and services provider to the U.S. commercial and federal markets.

Our activities include developing the Project IKE uranium enrichment facility in Oak Ridge, TN; storing, inspecting, transporting, and managing used nuclear fuel; conducting federal site clean-up and closure; dismantling and decontaminating radioactive components and shutdown nuclear energy facilities; and supplying U.S. nuclear energy utilities with uranium, conversion, and enrichment services.

In the nuclear medicine field, Orano Med is developing a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb), a rare alpha-emitting radioisotope and one of the more potent therapeutic payloads against cancer cells.